 | • レポートコード：QYR2104Z1339 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、131ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、循環腫瘍細胞（CTC）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（CTC濃縮、CTC検出、CTC分析）、用途別市場規模（乳がん、前立腺がん、大腸がん、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・循環腫瘍細胞（CTC）の市場動向 ・企業の競争状況、市場シェア ・循環腫瘍細胞（CTC）の種類別市場規模（CTC濃縮、CTC検出、CTC分析） ・循環腫瘍細胞（CTC）の用途別市場規模（乳がん、前立腺がん、大腸がん、その他） ・循環腫瘍細胞（CTC）の北米市場規模2016-2027（アメリカ、カナダ） ・循環腫瘍細胞（CTC）のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・循環腫瘍細胞（CTC）のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・循環腫瘍細胞（CTC）の中南米市場規模2016-2027（メキシコ、ブラジル） ・循環腫瘍細胞（CTC）の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Menarini-Silicon Biosystems、Qiagen（Adnagen）、Clearbridge Biomedics、Celsee、Fluidigm、ApoCell、Greiner Bio-one GmbH、Advanced Cell Diagnostics、Aviva Biosciences、Fluxion Biosciences、Sysmex Corporation、Epic Sciences、Cynvenio、CytoTrack、Ikonisys、Vortex BioSciences、Gilupi、Biocept、ScreenCell、ANGLE） ・結論 |
Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of these markers in monitoring disease progression and potentially guiding personalized cancer therapy.
The classification of Circulating Tumor Cells (CTCs) products includes CTC enrichment, CTC detection and CTC analysis, and the revenue proportion of CTC enrichment in 2016 is about 43.74%.
Market Analysis and Insights: Global Circulating Tumor Cell Market
The global Circulating Tumor Cell market size is projected to reach US$ 13790 million by 2026, from US$ 6202.8 million in 2019, at a CAGR of 12.0% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Circulating Tumor Cell market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Circulating Tumor Cell market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Circulating Tumor Cell market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Circulating Tumor Cell market.
Global Circulating Tumor Cell Scope and Market Size
Circulating Tumor Cell market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Circulating Tumor Cell market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
CTC Enrichment
CTC Detection
CTC Analysis
Segment by Application
Breast Cancer
Prostate Cancer
Colorectal Cancer
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Menarini-Silicon Biosystems
Qiagen（Adnagen）
Clearbridge Biomedics
Celsee
Fluidigm
ApoCell
Greiner Bio-one GmbH
Advanced Cell Diagnostics
Aviva Biosciences
Celsee
Fluidigm
Epic Sciences
Cynvenio
CytoTrack
Ikonisys
Vortex BioSciences
Gilupi
Biocept
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Circulating Tumor Cell Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 CTC Enrichment
1.2.3 CTC Detection
1.2.4 CTC Analysis
1.3 Market by Application
1.3.1 Global Circulating Tumor Cell Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Breast Cancer
1.3.3 Prostate Cancer
1.3.4 Colorectal Cancer
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Circulating Tumor Cell Market Perspective (2016-2027)
2.2 Circulating Tumor Cell Growth Trends by Regions
2.2.1 Circulating Tumor Cell Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Circulating Tumor Cell Historic Market Share by Regions (2016-2021)
2.2.3 Circulating Tumor Cell Forecasted Market Size by Regions (2022-2027)
2.3 Circulating Tumor Cell Industry Dynamic
2.3.1 Circulating Tumor Cell Market Trends
2.3.2 Circulating Tumor Cell Market Drivers
2.3.3 Circulating Tumor Cell Market Challenges
2.3.4 Circulating Tumor Cell Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Circulating Tumor Cell Players by Revenue
3.1.1 Global Top Circulating Tumor Cell Players by Revenue (2016-2021)
3.1.2 Global Circulating Tumor Cell Revenue Market Share by Players (2016-2021)
3.2 Global Circulating Tumor Cell Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Circulating Tumor Cell Revenue
3.4 Global Circulating Tumor Cell Market Concentration Ratio
3.4.1 Global Circulating Tumor Cell Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Circulating Tumor Cell Revenue in 2020
3.5 Circulating Tumor Cell Key Players Head office and Area Served
3.6 Key Players Circulating Tumor Cell Product Solution and Service
3.7 Date of Enter into Circulating Tumor Cell Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Circulating Tumor Cell Breakdown Data by Type
4.1 Global Circulating Tumor Cell Historic Market Size by Type (2016-2021)
4.2 Global Circulating Tumor Cell Forecasted Market Size by Type (2022-2027)
5 Circulating Tumor Cell Breakdown Data by Application
5.1 Global Circulating Tumor Cell Historic Market Size by Application (2016-2021)
5.2 Global Circulating Tumor Cell Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Circulating Tumor Cell Market Size (2016-2027)
6.2 North America Circulating Tumor Cell Market Size by Type
6.2.1 North America Circulating Tumor Cell Market Size by Type (2016-2021)
6.2.2 North America Circulating Tumor Cell Market Size by Type (2022-2027)
6.2.3 North America Circulating Tumor Cell Market Size by Type (2016-2027)
6.3 North America Circulating Tumor Cell Market Size by Application
6.3.1 North America Circulating Tumor Cell Market Size by Application (2016-2021)
6.3.2 North America Circulating Tumor Cell Market Size by Application (2022-2027)
6.3.3 North America Circulating Tumor Cell Market Size by Application (2016-2027)
6.4 North America Circulating Tumor Cell Market Size by Country
6.4.1 North America Circulating Tumor Cell Market Size by Country (2016-2021)
6.4.2 North America Circulating Tumor Cell Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Circulating Tumor Cell Market Size (2016-2027)
7.2 Europe Circulating Tumor Cell Market Size by Type
7.2.1 Europe Circulating Tumor Cell Market Size by Type (2016-2021)
7.2.2 Europe Circulating Tumor Cell Market Size by Type (2022-2027)
7.2.3 Europe Circulating Tumor Cell Market Size by Type (2016-2027)
7.3 Europe Circulating Tumor Cell Market Size by Application
7.3.1 Europe Circulating Tumor Cell Market Size by Application (2016-2021)
7.3.2 Europe Circulating Tumor Cell Market Size by Application (2022-2027)
7.3.3 Europe Circulating Tumor Cell Market Size by Application (2016-2027)
7.4 Europe Circulating Tumor Cell Market Size by Country
7.4.1 Europe Circulating Tumor Cell Market Size by Country (2016-2021)
7.4.2 Europe Circulating Tumor Cell Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Circulating Tumor Cell Market Size (2016-2027)
8.2 Asia-Pacific Circulating Tumor Cell Market Size by Type
8.2.1 Asia-Pacific Circulating Tumor Cell Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Circulating Tumor Cell Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Circulating Tumor Cell Market Size by Type (2016-2027)
8.3 Asia-Pacific Circulating Tumor Cell Market Size by Application
8.3.1 Asia-Pacific Circulating Tumor Cell Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Circulating Tumor Cell Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Circulating Tumor Cell Market Size by Application (2016-2027)
8.4 Asia-Pacific Circulating Tumor Cell Market Size by Region
8.4.1 Asia-Pacific Circulating Tumor Cell Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Circulating Tumor Cell Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Circulating Tumor Cell Market Size (2016-2027)
9.2 Latin America Circulating Tumor Cell Market Size by Type
9.2.1 Latin America Circulating Tumor Cell Market Size by Type (2016-2021)
9.2.2 Latin America Circulating Tumor Cell Market Size by Type (2022-2027)
9.2.3 Latin America Circulating Tumor Cell Market Size by Type (2016-2027)
9.3 Latin America Circulating Tumor Cell Market Size by Application
9.3.1 Latin America Circulating Tumor Cell Market Size by Application (2016-2021)
9.3.2 Latin America Circulating Tumor Cell Market Size by Application (2022-2027)
9.3.3 Latin America Circulating Tumor Cell Market Size by Application (2016-2027)
9.4 Latin America Circulating Tumor Cell Market Size by Country
9.4.1 Latin America Circulating Tumor Cell Market Size by Country (2016-2021)
9.4.2 Latin America Circulating Tumor Cell Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Circulating Tumor Cell Market Size (2016-2027)
10.2 Middle East & Africa Circulating Tumor Cell Market Size by Type
10.2.1 Middle East & Africa Circulating Tumor Cell Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Circulating Tumor Cell Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Circulating Tumor Cell Market Size by Type (2016-2027)
10.3 Middle East & Africa Circulating Tumor Cell Market Size by Application
10.3.1 Middle East & Africa Circulating Tumor Cell Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Circulating Tumor Cell Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Circulating Tumor Cell Market Size by Application (2016-2027)
10.4 Middle East & Africa Circulating Tumor Cell Market Size by Country
10.4.1 Middle East & Africa Circulating Tumor Cell Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Circulating Tumor Cell Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Menarini-Silicon Biosystems
11.1.1 Menarini-Silicon Biosystems Company Details
11.1.2 Menarini-Silicon Biosystems Business Overview
11.1.3 Menarini-Silicon Biosystems Circulating Tumor Cell Introduction
11.1.4 Menarini-Silicon Biosystems Revenue in Circulating Tumor Cell Business (2016-2021)
11.1.5 Menarini-Silicon Biosystems Recent Development
11.2 Qiagen（Adnagen）
11.2.1 Qiagen（Adnagen） Company Details
11.2.2 Qiagen（Adnagen） Business Overview
11.2.3 Qiagen（Adnagen） Circulating Tumor Cell Introduction
11.2.4 Qiagen（Adnagen） Revenue in Circulating Tumor Cell Business (2016-2021)
11.2.5 Qiagen（Adnagen） Recent Development
11.3 Clearbridge Biomedics
11.3.1 Clearbridge Biomedics Company Details
11.3.2 Clearbridge Biomedics Business Overview
11.3.3 Clearbridge Biomedics Circulating Tumor Cell Introduction
11.3.4 Clearbridge Biomedics Revenue in Circulating Tumor Cell Business (2016-2021)
11.3.5 Clearbridge Biomedics Recent Development
11.4 Celsee
11.4.1 Celsee Company Details
11.4.2 Celsee Business Overview
11.4.3 Celsee Circulating Tumor Cell Introduction
11.4.4 Celsee Revenue in Circulating Tumor Cell Business (2016-2021)
11.4.5 Celsee Recent Development
11.5 Fluidigm
11.5.1 Fluidigm Company Details
11.5.2 Fluidigm Business Overview
11.5.3 Fluidigm Circulating Tumor Cell Introduction
11.5.4 Fluidigm Revenue in Circulating Tumor Cell Business (2016-2021)
11.5.5 Fluidigm Recent Development
11.6 ApoCell
11.6.1 ApoCell Company Details
11.6.2 ApoCell Business Overview
11.6.3 ApoCell Circulating Tumor Cell Introduction
11.6.4 ApoCell Revenue in Circulating Tumor Cell Business (2016-2021)
11.6.5 ApoCell Recent Development
11.7 Greiner Bio-one GmbH
11.7.1 Greiner Bio-one GmbH Company Details
11.7.2 Greiner Bio-one GmbH Business Overview
11.7.3 Greiner Bio-one GmbH Circulating Tumor Cell Introduction
11.7.4 Greiner Bio-one GmbH Revenue in Circulating Tumor Cell Business (2016-2021)
11.7.5 Greiner Bio-one GmbH Recent Development
11.8 Advanced Cell Diagnostics
11.8.1 Advanced Cell Diagnostics Company Details
11.8.2 Advanced Cell Diagnostics Business Overview
11.8.3 Advanced Cell Diagnostics Circulating Tumor Cell Introduction
11.8.4 Advanced Cell Diagnostics Revenue in Circulating Tumor Cell Business (2016-2021)
11.8.5 Advanced Cell Diagnostics Recent Development
11.9 Aviva Biosciences
11.9.1 Aviva Biosciences Company Details
11.9.2 Aviva Biosciences Business Overview
11.9.3 Aviva Biosciences Circulating Tumor Cell Introduction
11.9.4 Aviva Biosciences Revenue in Circulating Tumor Cell Business (2016-2021)
11.9.5 Aviva Biosciences Recent Development
11.10 Fluxion Biosciences
11.10.1 Fluxion Biosciences Company Details
11.10.2 Fluxion Biosciences Business Overview
11.10.3 Fluxion Biosciences Circulating Tumor Cell Introduction
11.10.4 Fluxion Biosciences Revenue in Circulating Tumor Cell Business (2016-2021)
11.10.5 Fluxion Biosciences Recent Development
11.11 Sysmex Corporation
11.11.1 Sysmex Corporation Company Details
11.11.2 Sysmex Corporation Business Overview
11.11.3 Sysmex Corporation Circulating Tumor Cell Introduction
11.11.4 Sysmex Corporation Revenue in Circulating Tumor Cell Business (2016-2021)
11.11.5 Sysmex Corporation Recent Development
11.12 Epic Sciences
11.12.1 Epic Sciences Company Details
11.12.2 Epic Sciences Business Overview
11.12.3 Epic Sciences Circulating Tumor Cell Introduction
11.12.4 Epic Sciences Revenue in Circulating Tumor Cell Business (2016-2021)
11.12.5 Epic Sciences Recent Development
11.13 Cynvenio
11.13.1 Cynvenio Company Details
11.13.2 Cynvenio Business Overview
11.13.3 Cynvenio Circulating Tumor Cell Introduction
11.13.4 Cynvenio Revenue in Circulating Tumor Cell Business (2016-2021)
11.13.5 Cynvenio Recent Development
11.14 CytoTrack
11.14.1 CytoTrack Company Details
11.14.2 CytoTrack Business Overview
11.14.3 CytoTrack Circulating Tumor Cell Introduction
11.14.4 CytoTrack Revenue in Circulating Tumor Cell Business (2016-2021)
11.14.5 CytoTrack Recent Development
11.15 Ikonisys
11.15.1 Ikonisys Company Details
11.15.2 Ikonisys Business Overview
11.15.3 Ikonisys Circulating Tumor Cell Introduction
11.15.4 Ikonisys Revenue in Circulating Tumor Cell Business (2016-2021)
11.15.5 Ikonisys Recent Development
11.16 Vortex BioSciences
11.16.1 Vortex BioSciences Company Details
11.16.2 Vortex BioSciences Business Overview
11.16.3 Vortex BioSciences Circulating Tumor Cell Introduction
11.16.4 Vortex BioSciences Revenue in Circulating Tumor Cell Business (2016-2021)
11.16.5 Vortex BioSciences Recent Development
11.17 Gilupi
11.17.1 Gilupi Company Details
11.17.2 Gilupi Business Overview
11.17.3 Gilupi Circulating Tumor Cell Introduction
11.17.4 Gilupi Revenue in Circulating Tumor Cell Business (2016-2021)
11.17.5 Gilupi Recent Development
11.18 Biocept
11.18.1 Biocept Company Details
11.18.2 Biocept Business Overview
11.18.3 Biocept Circulating Tumor Cell Introduction
11.18.4 Biocept Revenue in Circulating Tumor Cell Business (2016-2021)
11.18.5 Biocept Recent Development
11.18 ScreenCell
.1 ScreenCell Company Details
.2 ScreenCell Business Overview
.3 ScreenCell Circulating Tumor Cell Introduction
.4 ScreenCell Revenue in Circulating Tumor Cell Business (2016-2021)
.5 ScreenCell Recent Development
11.20 ANGLE
11.20.1 ANGLE Company Details
11.20.2 ANGLE Business Overview
11.20.3 ANGLE Circulating Tumor Cell Introduction
11.20.4 ANGLE Revenue in Circulating Tumor Cell Business (2016-2021)
11.20.5 ANGLE Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Circulating Tumor Cell Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of CTC Enrichment
Table 3. Key Players of CTC Detection
Table 4. Key Players of CTC Analysis
Table 5. Global Circulating Tumor Cell Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Circulating Tumor Cell Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Circulating Tumor Cell Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Circulating Tumor Cell Market Share by Regions (2016-2021)
Table 9. Global Circulating Tumor Cell Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Circulating Tumor Cell Market Share by Regions (2022-2027)
Table 11. Circulating Tumor Cell Market Trends
Table 12. Circulating Tumor Cell Market Drivers
Table 13. Circulating Tumor Cell Market Challenges
Table 14. Circulating Tumor Cell Market Restraints
Table 15. Global Circulating Tumor Cell Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Circulating Tumor Cell Market Share by Players (2016-2021)
Table 17. Global Top Circulating Tumor Cell Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Circulating Tumor Cell as of 2020)
Table 18. Ranking of Global Top Circulating Tumor Cell Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Circulating Tumor Cell Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Circulating Tumor Cell Product Solution and Service
Table 22. Date of Enter into Circulating Tumor Cell Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Circulating Tumor Cell Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Circulating Tumor Cell Revenue Market Share by Type (2016-2021)
Table 26. Global Circulating Tumor Cell Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Circulating Tumor Cell Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Circulating Tumor Cell Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Circulating Tumor Cell Revenue Market Share by Application (2016-2021)
Table 30. Global Circulating Tumor Cell Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Circulating Tumor Cell Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Circulating Tumor Cell Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Circulating Tumor Cell Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Circulating Tumor Cell Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Circulating Tumor Cell Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Circulating Tumor Cell Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Circulating Tumor Cell Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Circulating Tumor Cell Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Circulating Tumor Cell Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Circulating Tumor Cell Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Circulating Tumor Cell Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Circulating Tumor Cell Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Circulating Tumor Cell Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Circulating Tumor Cell Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Circulating Tumor Cell Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Circulating Tumor Cell Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Circulating Tumor Cell Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Circulating Tumor Cell Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Circulating Tumor Cell Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Circulating Tumor Cell Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Circulating Tumor Cell Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Circulating Tumor Cell Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Circulating Tumor Cell Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Circulating Tumor Cell Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Circulating Tumor Cell Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Circulating Tumor Cell Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Circulating Tumor Cell Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Circulating Tumor Cell Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Circulating Tumor Cell Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Circulating Tumor Cell Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Circulating Tumor Cell Market Size by Country (2022-2027) & (US$ Million)
Table 62. Menarini-Silicon Biosystems Company Details
Table 63. Menarini-Silicon Biosystems Business Overview
Table 64. Menarini-Silicon Biosystems Circulating Tumor Cell Product
Table 65. Menarini-Silicon Biosystems Revenue in Circulating Tumor Cell Business (2016-2021) & (US$ Million)
Table 66. Menarini-Silicon Biosystems Recent Development
Table 67. Qiagen（Adnagen） Company Details
Table 68. Qiagen（Adnagen） Business Overview
Table 69. Qiagen（Adnagen） Circulating Tumor Cell Product
Table 70. Qiagen（Adnagen） Revenue in Circulating Tumor Cell Business (2016-2021) & (US$ Million)
Table 71. Qiagen（Adnagen） Recent Development
Table 72. Clearbridge Biomedics Company Details
Table 73. Clearbridge Biomedics Business Overview
Table 74. Clearbridge Biomedics Circulating Tumor Cell Product
Table 75. Clearbridge Biomedics Revenue in Circulating Tumor Cell Business (2016-2021) & (US$ Million)
Table 76. Clearbridge Biomedics Recent Development
Table 77. Celsee Company Details
Table 78. Celsee Business Overview
Table 79. Celsee Circulating Tumor Cell Product
Table 80. Celsee Revenue in Circulating Tumor Cell Business (2016-2021) & (US$ Million)
Table 81. Celsee Recent Development
Table 82. Fluidigm Company Details
Table 83. Fluidigm Business Overview
Table 84. Fluidigm Circulating Tumor Cell Product
Table 85. Fluidigm Revenue in Circulating Tumor Cell Business (2016-2021) & (US$ Million)
Table 86. Fluidigm Recent Development
Table 87. ApoCell Company Details
Table 88. ApoCell Business Overview
Table 89. ApoCell Circulating Tumor Cell Product
Table 90. ApoCell Revenue in Circulating Tumor Cell Business (2016-2021) & (US$ Million)
Table 91. ApoCell Recent Development
Table 92. Greiner Bio-one GmbH Company Details
Table 93. Greiner Bio-one GmbH Business Overview
Table 94. Greiner Bio-one GmbH Circulating Tumor Cell Product
Table 95. Greiner Bio-one GmbH Revenue in Circulating Tumor Cell Business (2016-2021) & (US$ Million)
Table 96. Greiner Bio-one GmbH Recent Development
Table 97. Advanced Cell Diagnostics Company Details
Table 98. Advanced Cell Diagnostics Business Overview
Table 99. Advanced Cell Diagnostics Revenue in Circulating Tumor Cell Business (2016-2021) & (US$ Million)
Table 100. Advanced Cell Diagnostics Recent Development
Table 101. Aviva Biosciences Company Details
Table 102. Aviva Biosciences Business Overview
Table 103. Aviva Biosciences Circulating Tumor Cell Product
Table 104. Aviva Biosciences Revenue in Circulating Tumor Cell Business (2016-2021) & (US$ Million)
Table 105. Aviva Biosciences Recent Development
Table 106. Fluxion Biosciences Company Details
Table 107. Fluxion Biosciences Business Overview
Table 108. Fluxion Biosciences Circulating Tumor Cell Product
Table 109. Fluxion Biosciences Revenue in Circulating Tumor Cell Business (2016-2021) & (US$ Million)
Table 110. Fluxion Biosciences Recent Development
Table 111. Sysmex Corporation Company Details
Table 112. Sysmex Corporation Business Overview
Table 113. Sysmex Corporation Circulating Tumor Cell Product
Table 114. Sysmex Corporation Revenue in Circulating Tumor Cell Business (2016-2021) & (US$ Million)
Table 115. Sysmex Corporation Recent Development
Table 116. Epic Sciences Company Details
Table 117. Epic Sciences Business Overview
Table 118. Epic Sciences Circulating Tumor Cell Product
Table 119. Epic Sciences Revenue in Circulating Tumor Cell Business (2016-2021) & (US$ Million)
Table 120. Epic Sciences Recent Development
Table 121. Cynvenio Company Details
Table 122. Cynvenio Business Overview
Table 123. Cynvenio Circulating Tumor Cell Product
Table 124. Cynvenio Revenue in Circulating Tumor Cell Business (2016-2021) & (US$ Million)
Table 125. Cynvenio Recent Development
Table 126. CytoTrack Company Details
Table 127. CytoTrack Business Overview
Table 128. CytoTrack Circulating Tumor Cell Product
Table 129. CytoTrack Revenue in Circulating Tumor Cell Business (2016-2021) & (US$ Million)
Table 130. CytoTrack Recent Development
Table 131. Ikonisys Company Details
Table 132. Ikonisys Business Overview
Table 133. Ikonisys Circulating Tumor Cell Product
Table 134. Ikonisys Revenue in Circulating Tumor Cell Business (2016-2021) & (US$ Million)
Table 135. Ikonisys Recent Development
Table 136. Vortex BioSciences Company Details
Table 137. Vortex BioSciences Business Overview
Table 138. Vortex BioSciences Circulating Tumor Cell Product
Table 139. Vortex BioSciences Revenue in Circulating Tumor Cell Business (2016-2021) & (US$ Million)
Table 140. Vortex BioSciences Recent Development
Table 141. Gilupi Company Details
Table 142. Gilupi Business Overview
Table 143. Gilupi Circulating Tumor Cell Product
Table 144. Gilupi Revenue in Circulating Tumor Cell Business (2016-2021) & (US$ Million)
Table 145. Gilupi Recent Development
Table 146. Biocept Company Details
Table 147. Biocept Business Overview
Table 148. Biocept Circulating Tumor Cell Product
Table 149. Biocept Revenue in Circulating Tumor Cell Business (2016-2021) & (US$ Million)
Table 150. Biocept Recent Development
Table 151. ScreenCell Company Details
Table 152. ScreenCell Business Overview
Table 153. ScreenCell Circulating Tumor Cell Product
Table 154. ScreenCell Revenue in Circulating Tumor Cell Business (2016-2021) & (US$ Million)
Table 155. ScreenCell Recent Development
Table 156. ANGLE Company Details
Table 157. ANGLE Business Overview
Table 158. ANGLE Circulating Tumor Cell Product
Table 159. ANGLE Revenue in Circulating Tumor Cell Business (2016-2021) & (US$ Million)
Table 160. ANGLE Recent Development
Table 161. Research Programs/Design for This Report
Table 162. Key Data Information from Secondary Sources
Table 163. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Circulating Tumor Cell Market Share by Type: 2020 VS 2027
Figure 2. CTC Enrichment Features
Figure 3. CTC Detection Features
Figure 4. CTC Analysis Features
Figure 5. Global Circulating Tumor Cell Market Share by Application: 2020 VS 2027
Figure 6. Breast Cancer Case Studies
Figure 7. Prostate Cancer Case Studies
Figure 8. Colorectal Cancer Case Studies
Figure 9. Other Case Studies
Figure 10. Circulating Tumor Cell Report Years Considered
Figure 11. Global Circulating Tumor Cell Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Circulating Tumor Cell Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Circulating Tumor Cell Market Share by Regions: 2020 VS 2027
Figure 14. Global Circulating Tumor Cell Market Share by Regions (2022-2027)
Figure 15. Global Circulating Tumor Cell Market Share by Players in 2020
Figure 16. Global Top Circulating Tumor Cell Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Circulating Tumor Cell as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Circulating Tumor Cell Revenue in 2020
Figure 18. Global Circulating Tumor Cell Revenue Market Share by Type (2016-2021)
Figure 19. Global Circulating Tumor Cell Revenue Market Share by Type (2022-2027)
Figure 20. North America Circulating Tumor Cell Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Circulating Tumor Cell Market Share by Type (2016-2027)
Figure 22. North America Circulating Tumor Cell Market Share by Application (2016-2027)
Figure 23. North America Circulating Tumor Cell Market Share by Country (2016-2027)
Figure 24. United States Circulating Tumor Cell Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Circulating Tumor Cell Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Circulating Tumor Cell Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Circulating Tumor Cell Market Share by Type (2016-2027)
Figure 28. Europe Circulating Tumor Cell Market Share by Application (2016-2027)
Figure 29. Europe Circulating Tumor Cell Market Share by Country (2016-2027)
Figure 30. Germany Circulating Tumor Cell Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Circulating Tumor Cell Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Circulating Tumor Cell Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Circulating Tumor Cell Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Circulating Tumor Cell Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Circulating Tumor Cell Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Circulating Tumor Cell Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Circulating Tumor Cell Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Circulating Tumor Cell Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Circulating Tumor Cell Market Share by Region (2016-2027)
Figure 40. China Circulating Tumor Cell Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Circulating Tumor Cell Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Circulating Tumor Cell Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Circulating Tumor Cell Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Circulating Tumor Cell Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Circulating Tumor Cell Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Circulating Tumor Cell Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Circulating Tumor Cell Market Share by Type (2016-2027)
Figure 48. Latin America Circulating Tumor Cell Market Share by Application (2016-2027)
Figure 49. Latin America Circulating Tumor Cell Market Share by Country (2016-2027)
Figure 50. Mexico Circulating Tumor Cell Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Circulating Tumor Cell Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Circulating Tumor Cell Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Circulating Tumor Cell Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Circulating Tumor Cell Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Circulating Tumor Cell Market Share by Country (2016-2027)
Figure 56. Turkey Circulating Tumor Cell Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Circulating Tumor Cell Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Circulating Tumor Cell Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Menarini-Silicon Biosystems Revenue Growth Rate in Circulating Tumor Cell Business (2016-2021)
Figure 60. Qiagen（Adnagen） Revenue Growth Rate in Circulating Tumor Cell Business (2016-2021)
Figure 61. Clearbridge Biomedics Revenue Growth Rate in Circulating Tumor Cell Business (2016-2021)
Figure 62. Celsee Revenue Growth Rate in Circulating Tumor Cell Business (2016-2021)
Figure 63. Fluidigm Revenue Growth Rate in Circulating Tumor Cell Business (2016-2021)
Figure 64. ApoCell Revenue Growth Rate in Circulating Tumor Cell Business (2016-2021)
Figure 65. Greiner Bio-one GmbH Revenue Growth Rate in Circulating Tumor Cell Business (2016-2021)
Figure 66. Advanced Cell Diagnostics Revenue Growth Rate in Circulating Tumor Cell Business (2016-2021)
Figure 67. Aviva Biosciences Revenue Growth Rate in Circulating Tumor Cell Business (2016-2021)
Figure 68. Fluxion Biosciences Revenue Growth Rate in Circulating Tumor Cell Business (2016-2021)
Figure 69. Sysmex Corporation Revenue Growth Rate in Circulating Tumor Cell Business (2016-2021)
Figure 70. Epic Sciences Revenue Growth Rate in Circulating Tumor Cell Business (2016-2021)
Figure 71. Cynvenio Revenue Growth Rate in Circulating Tumor Cell Business (2016-2021)
Figure 72. CytoTrack Revenue Growth Rate in Circulating Tumor Cell Business (2016-2021)
Figure 73. Ikonisys Revenue Growth Rate in Circulating Tumor Cell Business (2016-2021)
Figure 74. Vortex BioSciences Revenue Growth Rate in Circulating Tumor Cell Business (2016-2021)
Figure 75. Gilupi Revenue Growth Rate in Circulating Tumor Cell Business (2016-2021)
Figure 76. Biocept Revenue Growth Rate in Circulating Tumor Cell Business (2016-2021)
Figure 77. ScreenCell Revenue Growth Rate in Circulating Tumor Cell Business (2016-2021)
Figure 78. ANGLE Revenue Growth Rate in Circulating Tumor Cell Business (2016-2021)
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed
世界の循環腫瘍細胞（CTC）・がん幹細胞（CSC）市場規模・現状・予測（2021年-2027年） The tumor cells which have shed into lymphatic system and circulated over the body through blood circulation are called as circulating tumor cells. Circulating tumor cells may comprise seeds for metastasis. Stem cells are the type of cells that can differentiate into specialized cells and have the c…- 世界の循環腫瘍細胞（CTC）予後技術市場規模・現状・予測（2021年-2027年） Circulating tumor cells (CTCs) are specialized rare cells, which have been shed from a primary solid tumor of the body and circulate in the vasculature system of the body, eventually causing metastasis. CTCs act as the seeds for successive development of additional metastatic tumors in distant organ…
- 世界の循環腫瘍細胞（CTC）市場規模・現状・予測（2021年-2027年） Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of these markers in monitoring disease progression and potenti…
- 世界の循環腫瘍細胞（CTC）診断市場規模・現状・予測（2021年-2027年） Circulatingtumorcells(CTCs)arecellsthathaveshed intothevasculatureorlymphaticsfrom a primarytumorand arecarried around thebodyintheblood circulation. Market Analysis and Insights: Global Circulating Tumor Cell (CTC) Diagnostics Market The global Circulating Tumor Cell (CTC) Diagnostics market size i…
- 世界の循環腫瘍細胞（CTC）診断市場規模・現状・予測（2021年-2027年） Circulating tumor cells are significantly useful in determining the status of disease progression rate and projection of therapy needed for tumor eradication. Further development of various tumor markers that can be used along with companion diagnostics to diagnose or monitor various forms of cancer…